Background

Pulmonary artery aneurysms (PAA) are rare abnormalities but could be potentially catastrophic if it gets ruptured. Sudden rupture could lead to death due to hemorrhage, aspiration, and asphyxia. The presenting symptoms could be hemoptysis, shortness of breath, chest pain, palpitations, or syncopal episodes (Sk and Shaikh 2014; Kreibich et al. 2015). Presence of pulmonary stenosis (PS) also poses challenges in anesthetic management in presence of PAA. PS increases intraventricular pressure and work of the right ventricle and affects left ventricular output due to pushing of the interventricular septum to the left. Anesthetic goals should be to maintain adequate right ventricular preload, avoid a decrease in systemic and pulmonary vascular resistance, and maintain normal sinus rhythm (Sk and Shaikh 2014). We report a case in which we managed a 74-year-old lady with a hip fracture for fixation under spinal anesthesia after thorough evaluation and meticulous planning. The patient was discharged home after 5 days without any perioperative events.

Case presentation

A 74-year-old lady, known hypertensive on lisinopril 10 mg and hydrochlorothiazide 12.5 mg sustained a fracture left hip due to a fall at home. She was reasonably active for her age with no history of dyspnea, productive cough, or chest pain. She was scheduled for a dynamic hip screw by the orthopedic team. Routine investigations (hemogram, renal function tests, coagulation profile) were unremarkable except for a right bundle branch block on the electrocardiogram. Chest radiograph revealed an ill-defined opacity around the left peri-hilar region. An echocardiogram was requested which revealed normal biventricular function with an ejection fraction of 60%, no regional wall motion abnormalities, concentric right ventricular hypertrophy (tricuspid annular plane systolic excursion or TAPSE of 19 mm), severe calcific pulmonary stenosis (PS) with pressures 90/61 mm Hg, pulmonary valve annulus of 12 mm, pulmonary artery systolic pressure of 35 mm Hg. The left and right pulmonary artery diameters were 17 mm and 20 mm, respectively. There were no intracardiac mass, thrombus, or pericardial effusion on echocardiography. As she was clinically asymptomatic and given the chest radiograph findings, the cardiologist advised a contrast-enhanced computed tomography (CT) scan of the chest which revealed aneurysmal dilatation of the main pulmonary trunk (52.2 mm in diameter), dilated right and left pulmonary arteries with no evidence of pulmonary embolism in the main branches. On further inquiry, the patient denied a history of any hemoptysis or connective tissue disorders to date. The cardiologist added 2.5 mg bisoprolol twice daily and the patient was accepted for dynamic hip screw under high-risk consent (Fig. 1).

Fig. 1
figure 1

A Chest radiograph PA view showing left perihilar opacity raising concerns (red arrow). B Axial view in chest CT showing dilated main pulmonary artery, right pulmonary artery, and ascending aorta. C Sagittal view in chest CT showing aneurysmal dilatation of main pulmonary artery. D Volume rendering technique CT showing aneurysmal dilatation of the main pulmonary artery

After shifting her to the operating room, two 18 G peripheral lines were secured and an arterial line was placed under local anesthesia. Monitoring included pulse-oximetry, cardio scope (lead 2, V5), and arterial blood pressure monitoring. Her baseline heart rate was 70 beats/min, blood pressure of 150/90 mm Hg, and oxygen saturation of 98% on room air with no dyspnea or tachypnea. A sequential lumbar epidural anesthesia was planned for this patient given her age, overall frail condition, and to avoid airway instrumentation. However, it was impossible to locate the epidural space due to the fused vertebra. We, therefore, co-loaded the patient with 250 ml crystalloid (Ringer lactate) and performed a subarachnoid block in L3–4 interspace under strict aseptic precautions using a 25G Quincke needle, and injected 7.5 mg of hyperbaric bupivacaine after confirming free flow of cerebrospinal fluid. Surgery was started after 20 min when an adequate level was achieved (T10). Surgery was accomplished uneventfully over 60 min with no hemodynamic changes with no requirement of vasoactive drugs (phenylephrine). One gram of paracetamol was infused intravenously during skin closure. Postoperatively she received oral tramadol 50 mg 8th hourly and paracetamol 1 g 8th hourly and also continued her antihypertensives along with 40 mg enoxaparin subcutaneously once daily for thromboprophylaxis. She had an uneventful course in the hospital and was discharged on the 5th postoperative day.

The patient has given consent for the images and other clinical information to be reported in the journal. The patient understands that the name and initials will not be published and due efforts will be made to conceal the identity.

Discussion

The mean diameter of the pulmonary artery is 25 mm + / − 3 mm. A mean diameter of more than 40 mm is considered a pulmonary artery aneurysm (PAA). A true aneurysm involves all the layers of the vessel and is therefore compliant. On the other hand, a pseudoaneurysm does not involve all three layers and is therefore risky with a higher tendency to rupture. The incidence of PAA is very rare (1 in 14,000) and occurs due to various causes like vasculitis, congenital heart disease (patent ductus arteriosus, atrial and ventricular septal defects, pulmonary stenosis, bicuspid aortic valve), connective tissue disorders (Ehlers-Danlos syndrome, Marfan syndrome, cystic medial necrosis), malignancy (lung cancer or pulmonary metastasis), post thoracic surgery, chronic pulmonary embolism, Behçet disease, and infection (tuberculosis, syphilis, endocarditis). It is usually detected incidentally during imaging for some other indications. In symptomatic patients, it could manifest as cough, dyspnea, hemoptysis, angina (due to pressure over the coronaries), airway compression, and pulmonary artery dissection (Gupta et al. 2020; Park et al. 2018; Theodoropoulos et al. 2013).

Medical management is offered when the patient is asymptomatic with mild to moderate pulmonary artery pressures. involves rate control (beta-blockers), statins, antiplatelets, and frequent imaging to monitor the size of the aneurysm. If the cause of PAA is established, the treatment can be initiated accordingly. Recommendations for surgical intervention are controversial, however, many experts advocate intervention for a PAA of more than 5.5 cm (Park et al. 2018).

This patient had severe calcific pulmonary stenosis which was responsible for right ventricular hypertrophy. There could be impaired left ventricular output due to pushing of the interventricular septum to the left. Therefore, cardiac output is maintained by systemic vascular resistance. A judicious preloading is essential to maintain right ventricular filling pressure but excessive fluids could precipitate right heart failure. The goal of the anesthetic technique is to optimize right ventricular preload, avoid an increase in pulmonary vascular resistance and decrease in systemic vascular resistance, maintain normal sinus rhythm, and maintain effective ventricular contractility (Shah et al. 2017; Sanikop et al. 2012).

We had planned lumbar epidural anesthesia which was technically difficult. We, therefore, administered a low-volume spinal anesthesia with cautious co-loading, monitoring rhythm abnormalities, and hemodynamics. Intraoperatively she received oxygen at 5 L/min via face mask as oxygen is a pulmonary vasodilator. She was advised to visit a higher center subsequently to follow up on her further management of PAA.

Conclusions

With this case report, we suggest that a central neuraxial blockade could be administered in presence of severe PS with meticulous monitoring and careful planning.